Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Dumbeldorfwhiteon Nov 20, 2024 1:40pm
111 Views
Post# 36322168

RE:RE:RE:RE:RE:RE:2025 Outlook

RE:RE:RE:RE:RE:RE:2025 Outlook Talk about over embellishing. No it's not side effect free. In fact 1 person died during the trial which given the investigation was declared unrelated but that doesn't mean the FDA won't want to hear what went wrong. Then the first 12 we're so underdosed how could they even get side effects so there's that so I could realistically see the FDa saying well you have 75 patients but in actuality it's only 63 patients. Then you go on to say the results are superior. They are on par and definitely behind the sunRISE trial results. Then you say o well it's low cost when in fact you have no idea how much TLT is going to charge per treatment and how that compares to other treatments. Unless you do know. How much is TLT looking to charge per treatment and how does that compare?
<< Previous
Bullboard Posts
Next >>